BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28646630)

  • 1. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: Differentiate it from No-ACLF.
    Wu W; Yan H; Zhao H; Sun W; Yang Q; Sheng J; Shi Y
    Liver Int; 2018 Feb; 38(2):248-257. PubMed ID: 28646630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure.
    Du XX; Shi Y; Yang Y; Yu Y; Lou HG; Lv FF; Chen Z; Yang Q
    Liver Int; 2018 Feb; 38(2):229-238. PubMed ID: 28640516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure.
    Wang Y; Chen C; Qi J; Wu F; Guan J; Chen Z; Zhu H
    J Transl Med; 2019 Mar; 17(1):93. PubMed ID: 30890164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus.
    Xiong L; Du Y; Zhou T; Du B; Visalath P; Lin L; Bao S; Cai W
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1800-1808. PubMed ID: 30771232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.
    Gao FY; Liu Y; Li XS; Ye XQ; Sun L; Geng MF; Wang R; Liu HM; Zhou XB; Gu LL; Liu YM; Wan G; Wang XB
    World J Gastroenterol; 2015 Jul; 21(27):8373-81. PubMed ID: 26217089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failure.
    Khanam A; Trehanpati N; Sarin SK
    Liver Int; 2019 Jun; 39(6):1062-1070. PubMed ID: 30506912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the circulating microbiome in acute-on-chronic liver failure associated with hepatitis B.
    Zhang Y; Zhao R; Shi D; Sun S; Ren H; Zhao H; Wu W; Jin L; Sheng J; Shi Y
    Liver Int; 2019 Jul; 39(7):1207-1216. PubMed ID: 30864226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
    Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
    Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
    Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of NLR versus MLR in the short-term prognostic assessment of HBV-related acute-on-chronic liver failure.
    Wang N; He S; Zheng Y; Wang L
    Int Immunopharmacol; 2023 Aug; 121():110489. PubMed ID: 37327515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.
    Liang XS; Li CZ; Zhou Y; Yin W; Liu YY; Fan WH
    World J Gastroenterol; 2014 Jul; 20(26):8558-71. PubMed ID: 25024610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.
    Li Q; Lu Q; Zhu MQ; Huang C; Yu KK; Huang YX; Zhao X; Luo XG; Zheng JM
    BMC Gastroenterol; 2020 Apr; 20(1):106. PubMed ID: 32293297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
    Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
    World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL.
    Wan Z; Xie G; Wu Y; Liu F; Xin S; You S; Liu H; Li C; Li D
    Dig Liver Dis; 2016 May; 48(5):528-535. PubMed ID: 26860239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.
    Tao YC; Wang ML; Wang M; Ma YJ; Bai L; Feng P; Chen EQ; Tang H
    Dig Liver Dis; 2019 Mar; 51(3):412-418. PubMed ID: 30274791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of neutrophil-lymphocyte ratio in predicting hepatitis B-related liver failure].
    Fan Y; Li X; Zhou XF; Zhang DZ; Shi XF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):726-731. PubMed ID: 29108199
    [No Abstract]   [Full Text] [Related]  

  • 17. NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.
    Jia Y; Ma L; Wang Y; Wang W; Shen C; Wang X; Xu H; Zhao C
    Mol Immunol; 2020 Apr; 120():179-186. PubMed ID: 32169738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Li TP; Guan SH; Wang Q; Chen LW; Yang K; Zhang H
    World J Gastroenterol; 2019 Oct; 25(37):5667-5675. PubMed ID: 31602166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF.
    Li J; Liang X; Jiang J; Yang L; Xin J; Shi D; Lu Y; Li J; Ren K; Hassan HM; Zhang J; Chen P; Yao H; Li J; Wu T; Jin L; Ye P; Li T; Zhang H; Sun S; Guo B; Zhou X; Cai Q; Chen J; Xu X; Huang J; Hao S; He J; Xin S; Wang D; Trebicka J; Chen X; Li J;
    Gut; 2022 Jan; 71(1):163-175. PubMed ID: 33431576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease.
    Hu X; Ma S; Huang X; Jiang X; Zhu X; Gao H; Xu M; Sun J; Abbott WG; Hou J
    J Viral Hepat; 2011 Jul; 18(7):458-67. PubMed ID: 21692955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.